Alembic Pharmaceuticals Limited, a leading global pharmaceutical company, combines innovation and excellence to deliver high-quality healthcare solutions that improve lives worldwide. With a commitment to scientific advancement and a customer-centric approach, we strive to make a positive impact on the well-being of individuals and communities.
Globally recognised for our strengths in R&D, manufacturing, product commercialisation as well as compliance with international regulatory standards.
For over a century, we've pioneered global healthcare advancements, ensuring widespread access to life-enhancing medicines, and leaving a lasting impact on human well-being.
Guided by the Alembic group's vision and legacy, our leadership team inspires us to reach new heights while staying true to our values.
Our growth story thrives on strategic partnerships, where our associates leverage our pharmaceutical industry expertise, quality, and insights for mutual benefit.
Alembic Pharmaceuticals Limited has earned esteemed accolades for its excellence, innovation, and transformative impact in healthcare.
Alembic Pharmaceuticals Limited's D&B reports and certificates affirm its financial strength, operational excellence, and industry adherence.
As a vertically integrated leader in healthcare and life sciences, we identify and address industry gaps, excelling in research, development, manufacturing, and commercialization to provide our clients with large-scale, high-quality, and timely product delivery.
As a vertically integrated drugs manufacturer, we develop in-house APIs, expanding our portfolio globally, ensuring quality assurance and delivery at scale, solidifying our position in the API business.
As a science-led, growth-oriented organization, our primary objective is to deliver unparalleled returns and increased value to our shareholders by introducing groundbreaking pharmaceutical and consumer healthcare products.
Alembic Pharmaceuticals Limited ensures transparent and accurate financial information, empowering stakeholders with comprehensive insights into its fiscal performance.
We provide timely and detailed quarterly results, enabling stakeholders to track the company's financial performance and make informed decisions.
We presents concise and informative investor updates, providing key financial insights and growth prospects.
Our annual reports provide in-depth financial insights and highlight key achievements and strategic endeavours.
We offer frequent business updates, keeping stakeholders informed about financial progress and operational advancements.
Alembic Pharmaceuticals Limited upholds strong corporate governance practices, ensuring transparency, accountability, and responsible decision-making for the benefit of its investors.
By fostering effective accountability, we empower our management team to convert opportunities into achievements, driving the progress of the company for the benefit of stakeholders.
Our leadership team, deeply connected to the Alembic group, preserves the founding vision, motivating the entire company to achieve new heights while staying true to our values.
We ensure a well-structured composition of committees, promoting robust corporate governance practices and diverse expertise within the organization.
Alembic Pharmaceuticals Limited maintains robust policies and codes, promoting ethical conduct and responsible business practices in line with strong corporate governance.
We follow transparent criteria for payments to Non-Executive Directors, upholding strong corporate governance practices.
Alembic Pharmaceuticals Limited demonstrates its commitment to Corporate Social Responsibility, driving positive impact through sustainable initiatives that benefit both society and investors.
We provide comprehensive shareholder information, ensuring transparency and effective communication to empower investors with relevant updates and resources.
We disclose our shareholding pattern, providing a clear overview of the distribution and ownership of shares among its stakeholders.
We promptly share notices, correspondences, and disclosures, ensuring transparent and effective communication with its shareholders.
We comply with IEPF guidelines, protecting shareholder interests and facilitating unclaimed dividend and share processes.
We provide necessary information and processes for the resolution of unpaid/unclaimed dividends, ensuring proper communication and support for shareholders.
We share pertinent information on Qualified Institutional Placement (QIP), keeping shareholders informed about the company's fundraising activities and opportunities.
We share our MOA and AOA, providing shareholders with insights into the company's legal framework and governance structure.
We conduct a shareholder familiarization program to enhance understanding of the company's operations and corporate governance.
We share Aleor and APL Scheme details, ensuring transparency for shareholders during restructuring.
Alembic Pharmaceuticals Limited informs shareholders about the reorganization of general reserves through the Scheme of Arrangement, providing insights into the restructuring process.
We disclose information regarding its subsidiaries, associates, and joint ventures, offering investors insights into the company's diversified business interests.
We maintain a strong investor relations program, fostering effective communication and building relationships with investors to ensure transparency and trust.
Alembic Pharmaceuticals Limited provides necessary investor-related forms, facilitating streamlined processes and efficient communication with shareholders.
We adhere to TDS (Tax Deducted at Source) regulations on dividend payments, ensuring compliance and providing relevant information to investors.
Alembic Pharmaceuticals Limited complies with SEBI (LODR) Regulations, ensuring transparent and timely disclosure of information to investors.
We ensure compliance with Regulation 62 of SEBI (LODR) Regulations, enabling transparent disclosure of relevant information for the benefit of investors.
Alembic Pharmaceuticals Limited actively collaborates with media platforms to ensure effective dissemination of company updates, achievements, and industry developments.
We issue press releases to provide timely and accurate information to media outlets, ensuring transparent and comprehensive communication with the public.
We share news and insights, offering valuable information and industry perspectives to media outlets and stakeholders.
The campus of Alembic Pharmaceuticals Limited provides a state-of-the-art environment, fostering innovation and collaboration for its employees in pursuit of scientific excellence.
To report an adverse event related to an Alembic product, stakeholders can access dedicated channels for timely and efficient communication and ensure prompt attention to safety concerns.
As a prominent Indian pharmaceutical company, we strive to enhance capacities for high-quality solutions, leveraging manufacturing expertise and innovation to foster customer loyalty, brand recognition, and a positive impact on people's lives.
Alembic's manufacturing culture of excellence, with world-class facilities and skilled workforce, ensures efficient production, top-quality standards, and agility to meet evolving market demands.
With advanced technologies, strategic partnerships, and a dedicated team, we drive R&D advancements in high-growth therapies, aiming for leadership in markets with a strong product pipeline including specialty and complex generics.
Our unwavering commitment to quality, compliance, and adherence to global standards earns us the trust and loyalty of customers, partners, and regulatory bodies worldwide.
Creating societal value through community engagement, ethics, and charitable efforts, we have earned stakeholder trust as a trusted brand, exemplified by the establishment of the Alembic CSR Foundation in 2015 with dedicated task forces in Education, Health, and Community Development.
By adopting schools and improving facilities, we empower communities through quality education, fostering a resilient society.
At Alembic, our mission is to promote equitable access to quality healthcare, transforming lives and saving countless souls.
To ensure access to quality medicines for all, we drive sustainable development initiatives and tackle pressing societal challenges through our Foundation's dedicated efforts.
As a science-led and research-driven organization, we foster a culture of continuous learning, collaboration, and openness, leveraging the knowledge, expertise, and dedication of our people to drive our success
Our diverse team drives global healthcare solutions through meritocracy, recognition programs, and regular leadership reviews for coaching and barrier removal.
We foster a culture of continuous learning, collaboration, and openness to leverage the knowledge, expertise, and dedication of our people as a science-led, research-driven organization.